Literature DB >> 26038381

First report of Nocardia fusca isolated in humans.

María Ercibengoa Arana1, José María Marimón Ortiz de Zarate1.   

Abstract

Nocardia fusca was first described in 1983; however, to date, no report of human infection has been done. In this work, we report the first case of N. fusca isolation during an episode of acute exacerbation in a patient with chronic obstructive pulmonary disease. The extent of the role of N. fusca as human pathogen still has to be determined. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26038381      PMCID: PMC4460553          DOI: 10.1136/bcr-2015-209538

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Analysis of secA1 gene sequences for identification of Nocardia species.

Authors:  Patricia S Conville; Adrian M Zelazny; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

2.  Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.

Authors:  Julián Larruskain; Pedro Idigoras; José M Marimón; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  Clinical and microbiological features of nocardiosis 1997-2003.

Authors:  J Muñoz; B Mirelis; L M Aragón; N Gutiérrez; F Sánchez; M Español; O Esparcia; M Gurguí; P Domingo; P Coll
Journal:  J Med Microbiol       Date:  2007-04       Impact factor: 2.472

4.  Production of (R)-3-pentyn-2-ol through stereoinversion of racemic 3-pentyn-2-ol by Nocardia fusca AKU 2123.

Authors:  S X Xie; J Ogawa; S Shimizu
Journal:  Appl Microbiol Biotechnol       Date:  1999-09       Impact factor: 4.813

5.  NAD(+)-dependent (S)-specific secondary alcohol dehydrogenase involved in stereoinversion of 3-pentyn-2-ol catalyzed by Nocardia fusca AKU 2123.

Authors:  S X Xie; J Ogawa; S Shimizu
Journal:  Biosci Biotechnol Biochem       Date:  1999-10       Impact factor: 2.043

6.  Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

Authors:  A Telenti; F Marchesi; M Balz; F Bally; E C Böttger; T Bodmer
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

7.  Pulmonary nocardiosis in patients with COPD: characteristics and prognostic factors.

Authors:  Laia Garcia-Bellmunt; Oriol Sibila; Ingrid Solanes; Ferran Sanchez-Reus; Vicente Plaza
Journal:  Arch Bronconeumol       Date:  2012-05-30       Impact factor: 4.872

8.  Nocardiosis at the turn of the century.

Authors:  Maricela Valerio Minero; Mercedes Marín; Emilia Cercenado; Pablo Martín Rabadán; Emilio Bouza; Patricia Muñoz
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

Review 9.  Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis.

Authors:  Raquel Martínez; Soledad Reyes; Rosario Menéndez
Journal:  Curr Opin Pulm Med       Date:  2008-05       Impact factor: 3.155

10.  Clinical and radiographic characteristics of pulmonary nocardiosis: clues to earlier diagnosis.

Authors:  Junjun Chen; Hua Zhou; Panfeng Xu; Pei Zhang; Shanni Ma; Jianying Zhou
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.